[Preliminary report on the action of cyclobenzaprine (MK-130) in Parkinson's disease].
D000203:Activities of Daily Living; D000368:Aged; D003986:Dibenzocycloheptenes / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D011437:Propylamines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000209:etiology
D003986:Dibenzocycloheptenes; D011437:Propylamines; D004295:Dihydroxyphenylalanine
Rapport préliminaire sur l'action de la cyclobenzaprine (MK-130) dans la maladie de Parkinson.